Stephen Stahl | |
---|---|
![]() Stahl in 2018 | |
Born | |
Other names | Steve Stahl, Stephen Stahl, Stephen M. Stahl |
Alma mater | Northwestern University (BS, MD) University of Chicago (PhD) |
Occupation(s) | Psychiatrist, Neurologist |
Website | stevestahl |
Stephen Michael Stahl is an author and professor of psychiatry with expertise in psychopharmacology. He is currently a professor at the University of California, San Diego, and serves as Honorary Fellow in psychiatry department at the University of Cambridge. [1] He is also the chairman of Neuroscience Education Institute (NEI) and Arbor Scientia Group.
Stahl also serves as the Director of Psychopharmacology Services at the California Department of State Hospitals as well as the Editor-in Chief of CNS Spectrums.
He is an internationally recognized authority in psychiatry having published over 500 scientific papers, edited 12 textbooks and personally written 35 text books including the two best-selling textbooks in the field of psychiatry and psychopharmacology over the past twenty years. He has contributed significantly to the field of psychopharmacology through his research in the 70s, 80s and 90s, especially in the area of serotonin, schizophrenia and depression. In addition to his many academic contributions, Stahl is known for his 2015 novel Shell Shock and his expert contribution to exposing inadequate mental health care for returning soldiers from Iraq and Afghanistan. [2]
In 2002, The International College of Neuropsychopharmacology honoured Stahl with the Lundbeck Foundation Award in Education for contributions to postgraduate education in psychiatry and neurology.
Stahl was born in Wauseon, Ohio and raised in Bryan, Ohio. In 1973, he completed his B.S. degree from Northwestern University and received his M.D. there in 1975. In 1976, he received his Ph.D. in Neuropharmacology from the University of Chicago. Later he trained in internal medicine at the University of Chicago, in neurology at the University of California, San Francisco, and in psychiatry at Stanford University. He is board certified in psychiatry. In 1981, he completed his residency in psychiatry at Stanford and became the assistant director of the Stanford Mental Health Clinical Research Center and assistant professor of psychiatry and behavioral Sciences at Stanford University Medical School where he worked until 1985. [3] [4]
Stahl joined Stanford University in 1981 as an assistant professor of Psychiatry and Behavioural Sciences and taught there till 1985 when he became an adjunct associate professor of psychiatry and behavioural sciences and pharmacology at the University of California Los Angeles while working and living overseas in the UK where he taught at the Institute of Psychiatry, London as a Senior Lecturer and at the Institute of Neurology and the National Hospital for Nervous Diseases, London also as a Senior Lecturer. He served as an honorary consultant in psychiatry at the Maudsley Hospital, London from 1985 – 1988. In 1988, he joined University of California, San Diego as professor of psychiatry and chief of psychiatry at the San Diego Veterans Affairs Hospital. Currently he is an adjunct professor at the University of California San Diego. [5]
In 2009, he was selected as an honorary senior visiting fellow by the University of Cambridge. He also directs psychopharmacology services and academic programs for the California Department of State Hospital System, where he also heads their assessment and treatment efforts to reduce violence.
In 1981, he became the director of Movement Disorders & Psychopharmacology Research Clinic at Veterans Affairs Medical Center in Palo Alto and chief of the Schizophrenia Biological Research Center and served there till 1985. [5] Simultaneously, he also worked with the Alza Corporation as director of clinical sciences, associate medical director and principal scientist from 1982 to 1985 and then joined the Merck & Co. Research Laboratories and moved overseas to their Neuroscience Research Centre outside of London in 1985, where he stayed till 1988 as the director of the Laboratory of Clinical Neuropharmacology, head of a normal volunteer research unit, and executive director of research in Parkinson’s Disease ultimately leading to the registration of Sinemet CR for this condition.
He has also been a scientific consultant and member of scientific advisory boards for dozens of Pharmaceutical companies, medical information companies, and public service organizations including the state Medicaid drug utilization committee of California over the past 35 years. [6] He also serves as a member of the scientific advisory board for the psychiatric genomics company Genomind. [7]
Stahl is author of over 500 articles and book chapters and more than 1600 scientific presentations and abstracts. He has written 35 text books and edited 12 others, including the best-selling and award-winning Stahl’s Essential Psychopharmacology, now in its fifth edition and Essential Psychopharmacology Prescriber’s Guide, now in its seventh edition. [5] In 2015, he published the thriller novel Shell Shock. [8]
Stahl’s interests are dedicated to producing and disseminating educational information about diseases and their treatments in psychiatry and neurology, with a special emphasis on multimedia, the internet. [9]
Stahl had a major input related to revelations about inadequate mental health care in the US Army and at Fort Hood His role was to train caregivers of wounded soldiers and ensure that the current system was appropriate. [10] [11] [12]
Year | Award | Awarding Body |
---|---|---|
1971 | Illinois Psychiatric Society Award | Illinois Psychiatric Society |
1973 | Illinois Psychiatric Society Award | Illinois Psychiatric Society |
1974 | A.E. Bennett Award | Society of Biological Psychiatry |
1977 | Illinois Psychiatric Society Award | Illinois Psychiatric Society |
2002 | Lundbeck International Neuroscience Foundation Prize [15] | International College of Neuropsychopharmacology |
2004 | Education Award [3] | San Diego Psychiatric Society and the American Psychiatric Association |
2009 | Medical Book Competition Award | British Medical Association |
2010 | Book of the Year Award | British Medical Association |
2011 | Medical Book Competition Award | British Medical Association |
2013 | Distinguished Psychiatrist Award and Lecturer | American Psychiatric Association [16] |
2016 | David A Mrazek Memorial Award and Lecturer | American Psychiatric Association |
2018 | Honorary Doctorate [17] | Üsküdar University |
In 2015, Northwestern University, his alma mater, honored him by naming their annual award for the best medical student going into psychiatry the Stephen Stahl award.
Anthony David FMedSci is a British neuropsychiatrist based at University College London. Previously tenured as professor of cognitive neuropsychiatry and Vice Dean at the Institute of Psychiatry, King's College London, since 2018 he has been Director, University College London, Institute of Mental Health. He is the father of Rebecca David, a Senior Campaign Manager at Influencer LTD and Michael David a junior doctor.
The National Institute of Mental Health and Neuro-Sciences is a medical institution in Bangalore, India. NIMHANS is the apex centre for mental health and neuroscience education in the country. It is an Institute of National Importance operating autonomously under the Ministry of Health and Family Welfare. NIMHANS is ranked 4th best medical institute in India, in the current National Institutional Ranking Framework.
Stephen Vincent Faraone is an American psychologist. He has worked mainly on attention-deficit hyperactivity disorder and related disorders and is considered one of the most influential psychologists in the world.
Maximilian Fink is an American neurologist and psychiatrist best known for his work on ECT. His early work also included studies on the effect of psychoactive drugs on brain electrical activity; his later work has included books about the syndromes of catatonia and melancholia, published in the 2010s.
Kenneth L. Davis is the executive vice chairperson of the board of trustees at the Mount Sinai Health System in New York City, and an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's disease designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic to persons with Alzheimer's disease. His research led to four of the first five FDA-approved drugs for Alzheimer's.
Erminio "Mimo" Costa was an Italian-American neuroscientist. His research interests covered brain serotonergic activity in health and disease, benzodiazepine-GABA interactions, benzodiazepine action at GABAA receptors, neurophysiological role of neurosteroids, and GABAergic dysfunction and changes in the expression of reelin and GAD67 in schizophrenia. He published more than 1,000 articles. The June 2011 issue of the journal Neuropharmacology was dedicated to him.
Jeffrey Alan Lieberman is an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscience (biology) and pharmacological treatment. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing pharmacotherapies for schizophrenia. He was president of the American Psychiatric Association from May 2013 to May 2014.
David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Until 2009, he was a professor at the University of Bristol heading their Psychopharmacology Unit. Since then he has been the Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there. Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology.
Thomas Christian Südhof, ForMemRS, is a German-American biochemist known for his study of synaptic transmission. Currently, he is a professor in the school of medicine in the department of molecular and cellular physiology, and by courtesy in neurology, and in psychiatry and behavioral sciences at Stanford University.
John Raymond Smythies was a British neuropsychiatrist, neuroscientist and neurophilosopher.
Ira Glick is an American psychiatrist known for his research into the psychopathology and treatment of schizophrenia. He is currently Professor Emeritus of Psychiatry and Behavioral Sciences at Stanford Medical School, and Director of the Schizophrenia Research Clinic at Stanford Hospital.
Dilip V. Jeste is an American geriatric neuropsychiatrist, who specializes in successful aging as well as schizophrenia and other psychotic disorders in older adults. He was senior associate dean for healthy aging and senior care, distinguished professor of psychiatry and neurosciences, Estelle and Edgar Levi Memorial Chair in Aging, director of the Sam and Rose Stein Institute for Research on Aging, and co-director of the IBM-UCSD Artificial Intelligence Center for Healthy Living at the University of California, San Diego School of Medicine. after serving for 36 years, he retired from UC San Diego on July 1, 2022.
David McKenzie Rioch was a psychiatric research scientist and neuroanatomist, known as a pioneer in brain research and for leading the interdisciplinary neuropsychiatry division at the Walter Reed Army Institute of Research (1951–1970), a program that contributed to the formation of the then-nascent field of neuroscience.
Barry S. Fogel is an American neuropsychiatrist, behavioral neurologist, medical writer, medical educator and inventor. He is the senior author of a standard text in neuropsychiatry and medical psychiatry, and a founder of the American Neuropsychiatric Association and the International Neuropsychiatric Association.
F. Markus Leweke is a German psychiatrist and psychotherapist. He is a professor and Chair in Youth Depression Studies at the Brain and Mind Centre of the University of Sydney, Australia and a work group leader at the Central Institute of Mental Health in Mannheim, Germany.
Daniel R. Weinberger is a professor of psychiatry, neurology and neuroscience at Johns Hopkins University and Director and CEO of the Lieber Institute for Brain Development, which opened in 2011.
Walter Wolfgang Fleischhacker is an Austrian psychiatrist and psychotherapist. Previously professor of psychiatry at the Medical University Innsbruck, he was appointed president of the university on 1 October 2017.
Ganesan Venkatasubramanian is an Indian psychiatrist and clinician-scientist who works as a professor of psychiatry at the National Institute of Mental Health and Neurosciences, Bangalore (NIMHANS). His overarching research interest to learn the science that will facilitate a personalized approach to understand and treat severe mental disorders like schizophrenia. Venkatasubramanian is known for his studies in the fields of schizophrenia, transcranial Direct Current Stimulation (tDCS), brain imaging, neuroimmunology, neurometabolism and several other areas of biological psychiatry. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, for his contributions to medical sciences in 2018. He was also one of the collaborating scientists in the NIMHANS-IOB Bioinformatics and Proteomics laboratory of the Institute of Bioinformatics (IOB) in Bangalore and NIMHANS. Besides, he is an adjunct faculty at the Centre for Brain Research (CBR) in Bangalore.
Joseph Thomas Coyle Jr. is an American psychiatrist and neuroscientist. He is the Eben S. Draper Professor of Psychiatry and Neuroscience at Harvard Medical School.
Thomas A. Ban was a Hungarian-born Canadian psychiatrist, psychopharmacologist, academic, researcher and theorist.